Tag: epilepsy drug market

Protagenic Gets Japan Patent for Stilbenoid Drug Program

Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a…

Join Our Community

Join Our Community